|
Allon granted Australian patent for learning and memory compound
September 27, 2006
Canadian patient recruitment begins for Allon's AL-208 Phase II clinical trial
September 6, 2006
Angiotech Pharmaceuticals: Positive Preclinical Data on Vascular Wrap(TM) Presented at Vascular Conference
September 17, 2006
AnorMED announces receipt of proposal from Genzyme Corporation
October 10, 2006
AnorMED Board recommends shareholders accept Millennium offer
October 5, 2006
AnorMED board continues to recommend that shareholders accept Millennium's planned tender offer
October 4, 2006
Anormed Agrees to Support a Planned Tender Offer of US$12 Per Share From Millenium Pharmaceuticals
September 26, 2006
AnorMED reports on Annual General Meeting
September 20, 2006
AnorMED amends license agreement for cancer drug
September 19, 2006
Approval of Fosrenol in Germany Triggers US $13 Million Payment to Anormed
September 18, 2006
AnorMED Provides Update on Limited Duration Shareholder Rights Plan
September 15, 2006
AnorMED shares begin trading on NASDAQ
September 7, 2006
AnorMED Board recommends shareholders reject hostile Genzyme offer and not tender shares
September 5, 2006
Aspreva Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, England
September 13, 2006
Aspreva Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, England
September 12, 2006
BC Biotech Adds Two Industry Leaders to their Board of Directors
October 5, 2006
BC Biotech to use Flintbox for Biotechnology Industry Directory
October 3, 2006
Conversation on Healthcare Seen as Good for BC Biotech Industry
October 3, 2006
Cardiome Announces Filing of Shelf Registration Statement
October 10, 2006
Cardiome Announces USAN Name and Patent Grant
September 27, 2006
Cardiome to Present at UBS Global Life Sciences Conference
September 21, 2006
Cardiome Announces Positive Phase 2A Results for Oral RSD1235
September 13, 2006
Cardiome to Present at Bear Stearns Conference
September 7, 2006
British Columbia ranks second with eight companies on Deloitte’s Technology Fast 50 award
September 20, 2006
enGene, Inc. Adds Leading Diabetes and Gene Therapy Experts as Scientific Advisors
October 3, 2006
IBM Canada wins $24-million services agreement to build pan-Canadian communicable disease surveillance system
September 6, 2006
Dr. Bruce McManus to Lead Scientific Programs for the iCAPTURE Centre and the Heart Centre at St. Paul’s Hospital
September 18, 2006
INEX Updates Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
September 28, 2006
Shareholders of Inex Pharmaceuticals Approve Spin Out
September 21, 2006
INEX Receives Notice from Protiva Biotherapeutics
September 11, 2006
Inflazyme Pharmaceuticals Announces Date of its Annual General and Special Shareholders' Meeting
September 29, 2006
Inflazyme Pharmaceuticals Names Jeremy Curnock Cook as Chairman of Board of Directors
September 13, 2006
Forbes Medi-Tech Announces the Completion of the US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4
October 2, 2006
Forbes Medi-Tech Announces the Expansion of Reducol™-based Products at Kesko of Finland
September 5, 2006
Med BioGene enters development and validation phase for its Cardiovascular Disease Profiling System(TM)
September 25, 2006
Med BioGene to present at BioContact Québec 2006 in Québec City
September 19, 2006
MIGENIX to Present at the 46th Annual International Conference on Antimicrobial Agents and Chemotherapy
September 27, 2006
MIGENIX to Present at the UBS 2006 Global Life Science Conference
September 26, 2006
MIGENIX First Fiscal Quarter 2007 Financial Results Conference Call & Web Cast Notification
September 14, 2006
Nventa Announces Presentation of Positive HspE7 Data from Clinical Trial in Genital Warts
September 7, 2006
Nventa presents first data on HspE7 with adjuvants at International Conference
September 6, 2006
Ondine Biopharma Announces Results from Clinical Trial
October 4, 2006
Ondine Biopharma Receives CE Mark Approval for MRSA Decolonization
October 1, 2006
Perceptronix Attracts High Profile President and CEO Carl Roy joins Vancouver-based Cancer Diagnostics Company from Providence Health Care
September 27, 2006
Protox receives approval from Health Canada for BPH clinical trial
October 11, 2006
Protox Files Clinical Trial Application with Health Canada for BPH
September 21, 2006
QLT Provides Update on Massachusetts Eye and Ear Infirmary Litigation
October 6, 2006
QLT Announces Final Results of Tender Offer
September 14, 2006
QLT Announces Preliminary Results of Tender Offer
September 11, 2006
Twinstrand Therapeutics Inc. Announces Awards CDN$2.2M Research Contract by U.S. Dept of Defense for Development of a Medical Countermeasure to Ricin
September 12, 2006
UBC Research Garners High Scores in Latest International Surveys
September 21, 2006
UBC research major contributor to world's first tree genome
September 15, 2006
Welichem announces grant of incentive stock options
September 1, 2006
WEX Announces Option Exercise Price Reduction and Grant of Stock Options
October 6, 2006
Wex Announces Legal Proceedings Against Tianjin Fairwood
September 20, 2006
WEX Pharmaceuticals: President's Message
September 11, 2006
WEX Pharmaceuticals: Annual and Special Shareholders Meeting Update
September 8, 2006
Wex announces the continuation of tetrodotoxin development for cancer related pain
September 6, 2006
Xenon and Takeda Announce Agreement To Develop and Commercialize XEN401 for Pain in Japan and Certain Asian Countries
October 2, 2006
Xenon Pharmaceuticals announces a USD $5M investment by Takeda Research Investment
September 12, 2006 |
